Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

European Respiratory Journal

Volumn 23, Issue 3, 2004, Pages 363-368

  Christenson, B ^a   Hedlund, J ^b   Lundbergh, P ^a   Ortqvist A ^a,b  

^a Dept Commun Dis Contr Prevention ^*  (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Elderly; Influenza vaccine; Pneumococcal vaccine

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; PNEUMOKOCKVACCIN;

AGE DISTRIBUTION; AGED; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; STREPTOCOCCUS INFECTION; SWEDEN; TREATMENT OUTCOME; VACCINATION;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; SWEDEN; VACCINATION;

EID: 1542711374     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00063504     Document Type: Article

References (30)

1. Nichol KL. The additive benefit of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999; 17: S91-S93.
2. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among adults aged >65 years, United States, 1997. MMWR 1998; 47: 797-802.
3. Govaert ME, Thijs CTMCN, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. JAMA 1994; 272: 1661-1665.
4. Fedson DS, Hirota Y, Shin HK, et al. Influenza vaccination in 22 developed countries: An update to 1995. Vaccine 1997; 15: 1506-1511.
5. Centers for Disease Control and Prevention. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices. MMWR 1997; 46: 1-25.
6. American College of Physicians. Guide for Adult Immunization. 3rd Edn. Philadelphia, American College of Physicians, 1994.
7. Simberkoff MS, Cross AP, Al-Ibrahim M, et al. Efficacy of pneumococcal vaccine in high-risk patients. N Engl J Med 1986; 315: 1318-1327.
8. Örtqvist Å, Hedlund J, Burman L-Å, et al. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 1998; 351: 399-403.
9. Koivula I, Sten M, Leinonen M, Mäkelä PH. Clinical efficacy of pneumococcal vaccine in the elderly: A randomized, single-blind, population-based trial. Am J Med 1997; 103: 281-290.
10. Gaillat J, Zmirou D, Mallaret MR, et al. Clinical trial of pneumococcal vaccine among institutionalised elderly [Essai clinique du vaccin anti-pneumococcique chez des personnes]. Rev Epidémiol Santé Publique 1985; 33: 437-444.
11. Nicol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999; 159: 2437-2442.
12. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325: 1453-1460.
13. Farr BM, Johnston BL, Cobb DK, et al. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study. Arch Intern Med 1995; 155: 2336-2340.
14. Sims RV, Steinmann WC, McConville JH, King LR, Zwick WC, Schwartz JS. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988; 108: 653-657.
15. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993; 270: 1826-1831.
16. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: Implications for prevention. Arch Intern Med 1982; 142: 85-89.
17. Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992; 136: 296-307.
18. Fedson DS, Wajda A, Nicol P, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993; 270: 1956-1961.
19. Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: Cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121: 947-952.
20. Nichol KL, Margolis KL, Wuorenma J, von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-784.
21. Ahmed AH, Nicholson KG, Nguyen-van Tam JS, Pearson JCG. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiol Infect 1997; 118: 27-33.
22. Christenson B, Lundbergh P, Hedlund J, Örtqvist Å. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults 65 years and older: A prospective study. Lancet 2001; 357: 1008-1011.
23. Hedlund J, Christenson B, Lundbergh P, Örtqvist Å. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: A one-year follow-up. Vaccine 2003; 21: 3906-3911.
24. Christenson B, Lundbergh P. Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection. Epidemiol Infect 2002; 129: 515-524.
25. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998; 158: 1769-1776.
26. Gross PA, Hermogenes AW, Sacks HS, Lau J, Lewandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518-527.
27. Hanna JN, Young DM, Brookes DL, Dostie GB, Murphy DM. The initial coverage and impact of the pneumococcal and influenza vaccination program for at-risk indigenous adults in Far North Queensland. Aust NZ J Public Health 2001; 25: 543-546.
28. Gillick MR, Ditzon B. Influenza vaccination: Are we doing better than we think? Arch Intern Med 1991; 151: 1742-1744.
29. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322-1332.
30. Guevara RE, Butler JC, Marston BJ, Plouffe JF, File TM, Breiman RF. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 1999; 149: 282-289.